ÂÜÀòÂÒÂ×

Ulrich Tigges is a Principal Scientist at Enlaza Therapeutics, with a career spanning over two decades in biomedical research and interpretation. Previously, Ulrich held positions as a Senior Scientist at Truvian and as a Principal Scientist at Intertek Pharmaceutical Services, where extensive experience in various research methodologies was developed. Early roles included interpreting for diverse sectors and conducting fundamental research at prestigious institutions like Sanford Burnham Prebys Medical Discovery Institute and The Scripps Research Institute, focusing on cell signaling and vascular pathologies. Ulrich holds a PhD in Cell Biology from Technische Universität Braunschweig and a Master of Science in Biology from Bielefeld University.